Navigation Links
New understanding of basic units of memory
Date:9/19/2007

DURHAM, N.C. A molecular recycling plant permits nerve cells in the brain to carry out two seemingly contradictory functions changeable enough to record new experiences, yet permanent enough to maintain these memories over time.

The discovery of this molecular recycling plant, detailed in a study appearing early online Sept. 19 in the journal Neuron, provides new insights into how the basic units of learning and memory function. Individual memories are burned onto hundreds of receptors that are constantly in motion around nerve synapses gaps between individual nerve cells crucial for signals to travel throughout the brain.

According to the studys leader, Duke University Medical Center neurobiologist Michael Ehlers, M.D., Ph.D., these receptors are constantly moving around the synapse and often times they disappear or escape. Ehlers discovered that a specific set of molecules catch these elusive receptors, take them to the recycling plant where they are reprocessed and returned to the synapse intact.

These receptors constantly escape the synapse and are in a perpetual state of recycling, said Ehlers, who is also a Howard Hughes Medical Institute investigator. This process occurs on a time scale of minutes or hours, so the acquisition of new neurotransmitter receptors and their recycling is an on-going process. Memory loss may result from receptors escaping from the synapse.

All this activity takes place on millions of tiny nubs, or protrusions in the synapses known as dendritic spines. The recycling plants are located within the body of these dendritic spines.

We believe that the existence of this recycling ability explains in part how individual dendritic spines retain their unique identity amidst this constant molecular turnover, Ehlers said. The system is simultaneously dynamic and stable.

While these findings should be able to help neurobiologists as they attempt to understand the molecular foundations
'/>"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Understanding The Predictors Of Prostate Cancer
2. Understanding Restless Legs Syndrome
3. Understanding Lung Cancer Metastasis
4. Understanding The Link Between Hormone Replacement and Respiratory Disease
5. Understanding The Risks Of Hormone Therapy
6. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
7. A Better Understanding Of The Brain Network
8. Understanding The Predictor’s Of Alzheimer’s Diseae
9. Understanding The Harmful Effects Of Radiation Exposure
10. Understanding The Origin Of Tumors
11. Understanding Insulin Resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...rned patients on anti-depressants against taking w...lth's Medicines and Healthcare products Regulatory... of psychiatric reactions to drug, marketed as Aco...364) psychiatric reactions have been reported," it...
...crore Indian health insurance industry is poised t...wth rate of over 44 per cent per annum, it is one ...urers and even life insurers are jumping in the fr... Corporation of India (LIC), for instance, is pla...
..., for her upcoming tour bosses have asked her to s...he gig is over . According to a source, although ...by soon, she was bugged by the contract as no othe... to sign such contract. Its just a practical requ...
...rks about her, claiming that the actress is too ol...utcher tied the knot in September 2005, and the ac...by. Lesley Guynes, who is separated from Moores h...hat the 44-year-old actress was unable to have kid...
Other Medicine News:Health News:UK Reports Psychiatric Reactions to Weight-loss Drug Rimonabant 2Health News:Life Insurers in India to Launch Health Insurance Policies 2
(Date:9/4/2008)...stralia, Sept. 4 /- Cytopia Limited (...rolment for its Phase Ib/II,study of CYT997, the c...t,in patients with an aggressive form of brain ca... GBM clinical trial is the first Phase II efficacy... for the company and the second in its,suite of Ph...
(Date:9/4/2008)...ished in ,The Lancet, and Presented at ESC Congres... from a new international,study, the GISSI Heart F...,omega-3 acid ethyl esters reduced all cause morta...asons in patients with chronic heart,failure. Thes...sion of ,The,Lancet, and were presented at the Eur...
(Date:9/4/2008)...erland, September 4 /- Axentis Pharma...sess the safety and tolerability,of a new therapeu...ary,infection in cystic fibrosis patients. The new...nt to be delivered directly to the site of,infecti...fects of two,different doses of the new drug. Init...
(Date:9/4/2008)...ents Remain on Schedule with Two Abstracts Accepte...lease in November 2008, BRIDGEWATER, N.J., Sept. ...a specialty pharmaceutical company focused on the ... today announced the appointment of,Peter L. Garra...Peter Garrambone,s career includes more than 50 ph...
Breaking Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 1URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 2URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 3URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 4URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 5Keryx Biopharmaceuticals to Present at the Jefferies 26 Co Healthcare Conference 6180 1Keryx Biopharmaceuticals to Present at the Jefferies 26 Co Healthcare Conference 6180 2New Generation Biofuels Set to Join Russell Microcap Index 6178 1New Generation Biofuels Set to Join Russell Microcap Index 6178 2New Generation Biofuels Set to Join Russell Microcap Index 6178 3Astellas Launches Lexiscan 28TM 29 28Regadenoson 29 Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging 2 6176 1Astellas Launches Lexiscan 28TM 29 28Regadenoson 29 Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging 2 6176 2Astellas Launches Lexiscan 28TM 29 28Regadenoson 29 Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging 2 6176 3
...reated with VELCADE, cyclophosphamide,and prednis...7 /PRNewswire-FirstCall/ -- Millennium,Pharmaceuti...esults,from clinical trials of VELCADE based thera...e response(1) (CR) rates in previously,treated mul...resented at the prestigious 11th International Mye...
... Greece, June 29, 2007 /PRNewswire/ --,The Europea...viously treated patients on REVLIMID (lenalidomide...ival of 35 months, nearly,three years. The data ar...e III trials that enrolled more than 700 patients,...dated results,were presented at the 11th Internati...
Other Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2
...demand environments like OB/GYN, ER/Trauma, ICC/CC... delivers precision and control, plus consistent h...FESKIN* SATIN PLUS* Sterile Singles delive...excellent tactile sensitivity. The gloves are powd...
UROLOGY DRAPE. Soft translucent material for excellent shape conformity. Latex finger cot with additional adhesive ring around base. Full-width 50mm adhesive strip for secure fixing, with finger lift
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification
...the Penilab IV and the Penilab V have an exception...al studies. Model 1060 is similar to the Model 10...can one be added later. The Penilab V has a Doppl...of the accessories you'll need to get started. La...
Medicine Products: